Myovant Sciences

+$0.11 (+0.54%) As of 3:49 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYOV and other ETFs, options, and stocks.

About MYOV

Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on the development and commercialization of therapies for the treatment of women's health and endocrine diseases.

CEO
David C. Marek
Employees
407
Headquarters
London, Greater London
Founded
2016

MYOV Key Statistics

Market Cap
1.87B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
361.30K
High Today
$20.43
Low Today
$20.11
Open Price
$20.20
Volume
89.72K
52 Week High
$30.90
52 Week Low
$13.59

MYOV Earnings

-$0.99
-$0.66
-$0.33
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Available Oct 26, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure